Periodontal Disease Therapeutics Market Size, Share, Trends, Business development, Analysis And Opportunities 2018 - 2026

                                                                               
Periodontal therapies are products that are used to treat periodontitis.

  Periodontal Disease Therapeutics Market



Periodontal therapies are products that are used to treat periodontitis. Periodontitis is a bacterial infection that develops over time as a result of microbial plaque, also known as gum disease, colonising the tooth surface and below the gingival margin. Hormonal changes, smoking, poor dental hygiene, and some inherited factors all contribute to periodontal disease. Periodontal disease is characterised by the progressive loss of alveolar bone and is most commonly seen in adults.


Adults are the most common victims of periodontal disease. According to the Centers for Disease Control and Prevention (CDC), the prevalence of periodontitis in persons aged 30 and older in the United States was predicted to be over 50% in 2018, resulting in 64.7 million Americans. 8.7% of the individuals had mild periodontitis, 30% had intermediate periodontitis, and 8.5 percent had severe chronic periodontitis. The frequency of the disease rises with age, with periodontitis affecting 70% of persons aged 65 and more. Many environmental risk factors are linked to inflammatory responses, such as smoking, diabetes, and bad health behaviours, which drive the chronic inflammatory response in periodontitis and are advantageous to the Periodontal Disease Therapeutic Market.


Market Segmentation:

By Drug Type

  • Arestin
  • Atridox
  • Doxycycline
  • Metronidazole
  • Minocycline
  • Periochip
  • Others

By Distributor Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channel

By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Oral health and oral hygiene are serious problems all over the world. The high frequency of periodontal disease is driving up demand for dental care. Aging, smoking, poor oral hygiene, heredity, stress, and other medical conditions are all risk factors for periodontal disease.

The key players in operating in the periodontal disease therapeutic market include DenMat Holdings LLC., 3M, Valeant Pharmaceuticals International, Inc., Galderma S.A., Dexcel Pharma Ltd., Kaken Pharmaceutical Co., Ltd., and OraPharma Inc.

Comments

Popular posts from this blog

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.

Biolubricants Market Size, Share, Growth, Opportunities, Global Analysis and Opportunity Assessment 2019 – 2027

Shared Services Market by Function, By Number of Services and By Region – Global Opportunities & Forecast 2019 - 2027